BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23

• 

  Business

  BMO most bullish on Merck’s, bearish on BMS’ plans to contend with patent cliffs

  BMO Capital Markets is more impressed by Merck’s plans to replace lost Keytruda revenue than on Bristol Myers Squibb’s efforts to fill the expected void that will come from loss of exclusivity for both Opdivo and Eliquis.

  October 2, 2026

   · 

  4 min read

   · 

  Gabrielle Masson
• Press Releases

  IMPACT SHINE COMMUNICATIONS’ CEO, TRISTAN JERVIS SHARES INDUSTRY INSIGHTS IN LEADETH’S ‘WHAT WORKS IN B2B SALES & MARKETING’ PAPER

  October 2, 2026

   · 

  1 min read